Abstract This 2022 European Atherosclerosis Society lipoprotein (a)[Lp (a)] consensus
statement updates evidence for the role of Lp (a) in atherosclerotic cardiovascular disease …

Over the last 10 years, there have been advances on several aspects of lipoprotein (a)
which are reviewed in the present article. Since the standard immunoassays for measuring …

Abstract Lipoprotein (a)(Lp (a)) is a strange lipoprotein species causatively independently
and significantly associated with cardiovascular diseases and calcified aortic valve stenosis …

Calcific aortic valve disease (CAVD) is a common acquired valvulopathy, which carries a
high burden of mortality. Chronic inflammation has been postulated as the predominant …

Calcific aortic valve stenosis (CAVS) is the most common heart valve disorder among
humans. To date, no effective method has been identified to prevent this disease. Herein, we …

Importance Although an increased risk of ischemic cardiovascular disease has been
associated with rheumatoid arthritis (RA), the risk of aortic stenosis (AS) is unknown …

Background This study aimed to define changes in the metabolic and protein profiles of
patients with calcific aortic valve disease (CAVD). Methods and results We analyzed cardiac …

Lipoprotein (a)[Lp (a)] is a complex polymorphic lipoprotein comprised of a low-density
lipoprotein particle with one molecule of apolipoprotein B100 and an additional …

Background Echocardiographic indexes of aortic stenosis may not comprehensively reflect
disease morbidity. Plasma proteomic profiling may add prognostic value in these patients …

Mitochondrial dysfunction and immune cell infiltration play crucial yet incompletely
understood roles in the pathogenesis of calcific aortic valve disease (CAVD). This study …